These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 32276895)
1. Influence of age and co-medication on the concentration and efficacy of valproic acid in Chinese epilepsy children. Wang Y; Hu W; Li Z Pak J Pharm Sci; 2020 Mar; 33(2):537-542. PubMed ID: 32276895 [TBL] [Abstract][Full Text] [Related]
2. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy. Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517 [TBL] [Abstract][Full Text] [Related]
3. Effects of UGT1A6 and GABRA1 on Standardized Valproic Acid Plasma Concentrations and Treatment Effect in Children With Epilepsy in China. Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F Ther Drug Monit; 2016 Dec; 38(6):738-743. PubMed ID: 27855134 [TBL] [Abstract][Full Text] [Related]
4. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110 [TBL] [Abstract][Full Text] [Related]
5. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation. Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986 [TBL] [Abstract][Full Text] [Related]
6. Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy. Itoh H; Suzuki Y; Fujisaki K; Sato Y; Takeyama M Biol Pharm Bull; 2012; 35(6):971-4. PubMed ID: 22687541 [TBL] [Abstract][Full Text] [Related]
7. Effect of a Declined Plasma Concentration of Valproic Acid Induced by Meropenem on the Antiepileptic Efficacy of Valproic Acid. Gu C; Zhang Y; Yuan F; Huang K; Lin Z; Chen Q; Chen Y; Wu Y; Wang D; Wang S J Clin Lab Anal; 2024 Apr; 38(8):e25025. PubMed ID: 38563451 [TBL] [Abstract][Full Text] [Related]
8. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy. Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151 [TBL] [Abstract][Full Text] [Related]
9. Factors Influencing Sodium Valproate Serum Concentrations in Patients with Epilepsy Based on Logistic Regression Analysis. Lan X; Mo K; Nong L; He Y; Sun Y Med Sci Monit; 2021 Nov; 27():e934275. PubMed ID: 34776507 [TBL] [Abstract][Full Text] [Related]
10. Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children. Du Z; Jiao Y; Shi L Med Sci Monit; 2016 Oct; 22():4107-4113. PubMed ID: 27795544 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy. Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics? Miranda Herrero MC; Alcaraz Romero AJ; Escudero Vilaplana V; Fernández Lafever SN; Fernández-Llamazares CM; Barredo Valderrama E; Vázquez López M; de Castro P Eur J Paediatr Neurol; 2015 Mar; 19(2):155-61. PubMed ID: 25578527 [TBL] [Abstract][Full Text] [Related]
13. Valproic acid clearance in children with epilepsy. Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109 [TBL] [Abstract][Full Text] [Related]
14. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine. Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295 [TBL] [Abstract][Full Text] [Related]
15. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients. Wen D; Chen Z; Yang C; Liu H; Li H; Chen J; Dai Q; Zhong G; Qin J; Ni G; Huang M; Zhou L; Wang X J Pharm Biomed Anal; 2018 Feb; 149():448-456. PubMed ID: 29169113 [TBL] [Abstract][Full Text] [Related]
16. Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy. Zhao M; Chen Y; Wang M; Li G; Zhao L Ther Drug Monit; 2020 Oct; 42(5):760-765. PubMed ID: 32107351 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy. Rosenfeld WE; Liao S; Kramer LD; Anderson G; Palmer M; Levy RH; Nayak RK Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595 [TBL] [Abstract][Full Text] [Related]
18. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Otoul C; De Smedt H; Stockis A Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416 [TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication. May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling. Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]